Wat is de prijs voor OptiBiotix Health Plc (OPTI)

Het prijs van OptiBiotix Health Plc (OPTI) is $0.07994122

Wat is de marktkapitalisatie voor OptiBiotix Health Plc (OPTI)

Marktkapitalisatie voorOptiBiotix Health Plc (OPTI) is $82.58K

OptiBiotix Health Plc (OPTI) Uitstaande Aandelen

OptiBiotix Health Plc, a life sciences enterprise headquartered in York, United Kingdom, specializes in the discovery and advancement of microbiome-modulating technologies. The company formulates distinct microbial strains, innovative compounds, and tailored blends intended for integration into food products, nutritional supplements, and active ingredients. Their groundbreaking work aims to positively influence human physiology and yield substantial health benefits. Among its diverse product portfolio are Slimbiome, a natural ingredient for healthy and satiety-driven weight management, and SlimBiome Medical, a supplemental aid for weight control. Other offerings include CholBiome, a dietary supplement for maintaining healthy cholesterol; Lactobacillus plantarum LPLDL, a probiotic supporting cardiovascular health and overall well-being; LPGOS, a galactooligosaccharide utilized in food applications to mitigate cardiovascular risk factors and enhance general health; WellBiome, a functional fiber and mineral blend designed to bolster gut microbiome diversity and promote wellness; and Sweetbiotix, a sweetener for use in various foods and beverages. Ultimately, OptiBiotix's innovations are designed to prevent and manage prevalent chronic lifestyle diseases, including obesity, high cholesterol, and diabetes. The company was founded in 2012.

Jaar	Uitstaande aandelen	Wijzigen
2026 (TTM)	103.30M	5.51%
2024	97.90M	8.55%
2023	90.19M	2.16%
2022	88.28M	0.81%
2021	87.57M	0.42%
2020	87.21M	2.28%
2019	85.26M	3.68%
2018	82.23M	-6.37%
2017	87.83M	13.06%
2016	77.68M	6.17%
2015	73.17M	173.50%
2014	26.75M	4,286.24%
2013	609.91K	233.43%
2012	182.92K	20.40%
2011	151.93K	1,812.26%
2010	7.95K	0.00%
2009	7.95K	0.00%
2008	7.95K	-23.07%
2007	10.33K	0.00%

Jaar

Uitstaande aandelen

Wijzigen

2026 (TTM)

103.30M

5.51%

2024

97.90M

8.55%

2023

90.19M

2.16%

2022

88.28M

0.81%

2021

87.57M

0.42%

2020

87.21M

2.28%

2019

85.26M

3.68%

2018

82.23M

-6.37%

2017

87.83M

13.06%

2016

77.68M

6.17%

2015

73.17M

173.50%

2014

26.75M

4,286.24%

2013

609.91K

233.43%

2012

182.92K

20.40%

2011

151.93K

1,812.26%

2010

7.95K

0.00%

2009

7.95K

0.00%

2008

7.95K

-23.07%

2007

10.33K

0.00%

Bedrijf	Uitstaande aandelen	Verschil	Land
Vertex Pharmaceuticals Incorporated VRTX.US	253.90M	145.79%	US
Moderna, Inc. MRNA.US	396.00M	283.35%	US
Argenx SE ARGX.US	62.19M	-39.80%	NL
CSL Limited CSL.AX	478.91M	363.61%	AU
Lonza Group AG LONN.SW	-	-	CH

Bedrijf

Uitstaande aandelen

Verschil

Land